Project Details
Description
A Phase 3, Interventional, Randomized, Multicenter, Open-Label Study of DCC-2618 vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumors after Treatment with Imatinib
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/18 → 7/31/24 |
Funding
- DECIPHERA PHARMACEUTICALS, LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.